Cadence spikes 12.2% AH on rumored favorable court decision in Exela case

|By:, SA News Editor

Cadence Pharmaceuticals (CADX) shares rocket another 12.2% AH, adding to gains of 4.6% into the close, following word that a court has issued a favorable decision regarding blocking generic maker Exela Pharmaceuticals until 2021.